Skip to content

Study on the optimal dose of esketamine for patient-controlled epidural labor analgesia

Study on the optimal dose of esketamine for patient-controlled epidural labor analgesia

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200057662
Enrollment
Unknown
Registered
2022-03-15
Start date
2022-03-16
Completion date
Unknown
Last updated
2023-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epidural labor analgesia

Interventions

Group 2:0.075% ropivacaine + 0.25mg/ml esketamine
Group 3:0.075% ropivacaine + 0.5mg/ml esketamine
Group 4:0.075% ropivacaine + 0.75mg/ml esketamine
Group 5:0.075% ropivacaine + 1.0mg/ml esketamine

Sponsors

Zhejiang Xiaoshan Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Maternity aged 18 to 40; 2. ASA Class 1-2; 3. Height = 150 cm, weight = 100 kg; 4. Gestational age = 37 weeks; 5. Head position; 6. Cervical dilatation 3-7cm; 7. VAS = 30mm (0=no pain, 100=most painful).

Exclusion criteria

Exclusion criteria: 1. Intraspinal anesthesia contraindication; 2. People who are allergic to anesthetics and Esketamine; 3. Bradycardia; 4. Multiple pregnancy; 5. Preeclampsia; 6. Fetal abnormality; 7. Those who refuse to sign the informed consent form; 8. Other information: history of cesarean section, and parturients who have used sedatives or analgesics for a long time.

Design outcomes

Primary

MeasureTime frame
The effective rate of labor analgesia after 30 minutes of epidural loading.;

Secondary

MeasureTime frame
Maternal basic information;NRS (before analgesia, 30min, 60min, uterine opening, fetal delivery);Time of labor;Basic vital signs of parturient women;Use of anesthetic drugs after placenta delivery;Total press times of PCEA and effective press times;Mode of delivery;side effect;Neonatal outcome;

Countries

China

Contacts

Public ContactZhong Mei

Zhejiang Xiaoshan Hospital

meizhong@zju.edu.cn+86 18969979723

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026